EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterizing ceftriaxone tolerance in Neisseria gonorrhoeae across in vitro and in vivo models

Izumo Kanesaka iD, Anurag Kumar Bari, Saïd Abdellati, Thibaut Vanbaelen, Irith De Baetselier iD, Tessa de Block, Reinout Naesens, Basil Britto Xavier, John Rossen, Chris Kenyon iD, Sheeba Santhini Manoharan-Basil iD

mSystems · 2026

DOI: 10.1128/msystems.01298-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, 2026. Verfasst von Izumo Kanesaka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Ceftriaxone, Neisseria gonorrhoeae, Anti-Bacterial Agents, Gonorrhea. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to characterize the phenotypic behavior and in vivo persistence of a ceftriaxone-tolerant Neisseria gonorrhoeae clinical isolate from a single patient and evaluate the potential role of tolerance in treatment failure. A previously identified ceftriaxone-tolerant vaginal isolate was compared with isogenic and clinical non-tolerant strains. Bacterial growth was assessed in vitro , and tolerance was quantified using the minimum duration required to kill 99% of the population (MDK99), and persistence was evaluated in an in vivo Galleria mellonella infection model. Whole-genome sequencing (WGS) and transcriptomic (RNA-sequencing [RNA-seq]) profiling were performed to identify tolerance-associated genetic and transcriptional signatures. The tolerant strain exhibited prolonged MDK99 values across ceftriaxone concentrations, persisting for up to 24 hours under drug exposure. It also showed delayed early-phase growth, suggesting a fitness cost. In vivo , the tolerant strain remained viable up to 8 hours after treatment, whereas non-tolerant strains were cleared. WGS revealed identical gene content across all isolates, but non-synonymous mutations in pilE_3, a type IV pilin gene, were exclusively present in tolerant strains. RNA-seq analysis showed upregulation of pilin-associated genes and downregulation of zinc-independent ribosomal paralogs ( rpmE2 and ykgO ), suggesting a combined mechanism of surface remodeling and translational suppression associated with the tolerant phenotype. Ceftriaxone tolerance enables prolonged survival of N. gonorrhoeae despite apparent susceptibility by standard MIC-based testing. This phenotype may contribute to treatment failure, recurrent infection, and ongoing transmission, indicating the need for revised diagnostic and therapeutic strategies. IMPORTANCE Ceftriaxone remains the last reliable option for gonorrhea therapy, yet recurrent infections can occur despite isolates being classified as susceptible by MIC testing. One possible explanation is antibiotic tolerance, a phenotype that allows survival during drug exposure without changes in MIC. Although tolerance has been described in other pathogens, its role in gonococcal infection has remained poorly defined. In this study, we provide the first detailed characterization of a ceftriaxone-tolerant Neisseria gonorrhoeae clinical isolate associated with repeated treatment failure. By combining in vitro killing assays, an in vivo Galleria mellonella infection model, whole-genome sequencing, and transcriptomic profiling, we demonstrate that tolerance enables prolonged survival under ceftriaxone and is linked to pilin gene variation and ribosomal remodeling. These findings illustrate how a clinically observed phenomenon can be mechanistically dissected and emphasize tolerance as a hidden factor contributing to gonococcal persistence and potential treatment failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftriaxoneNeisseria gonorrhoeaeAnti-Bacterial AgentsGonorrheaDrug Resistance, BacterialAnimalsMicrobial Sensitivity TestsHumansFemaleWhole Genome SequencingDisease Models, AnimalThird Generation CephalosporinsGene Expression Profiling

Stichwörter der Autor:innen

Galleria mellonellaMDK99Neisseria gonorrhoeaeceftriaxonetolerancetreatment failure

Substanzen

CeftriaxoneAnti-Bacterial AgentsThird Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
  • Department of Infection Control and Prevention, Faculty of Nursing, Toho University, Tokyo, Japan.
  • Department of Medical Microbiology and Infection Prevention, Antimicrobial Resistance, Genomics and Epidemiology (AGE) Research Group, University Medical Center Groningen, University of Groningen, Groningen, the Netherl…
  • Department of Clinical Biology, ZAS, Antwerp, Belgium.
  • Laboratory of Medical Microbiology and Infectious Diseases and Isala Academy, Isala Hospital, Zwolle, the Netherlands.
  • Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA.

ORCID-Profile: Izumo Kanesaka, Irith De Baetselier, Chris Kenyon, Sheeba Santhini Manoharan-Basil

Zitieren

APA

Kanesaka, I., Kumar Bari, A., Abdellati, S., Vanbaelen, T., De Baetselier, I., de Block, T., Naesens, R., Britto Xavier, B., Rossen, J., Kenyon, C., & Manoharan-Basil, S. S. (2026). Characterizing ceftriaxone tolerance in Neisseria gonorrhoeae across in vitro and in vivo models. mSystems. https://doi.org/10.1128/msystems.01298-25

Vancouver

Kanesaka I, Kumar Bari A, Abdellati S, Vanbaelen T, De Baetselier I, de Block T, et al. Characterizing ceftriaxone tolerance in Neisseria gonorrhoeae across in vitro and in vivo models. mSystems. 2026. doi:10.1128/msystems.01298-25

BibTeX
@article{Kanesaka2026,
  author = {Kanesaka, Izumo and Kumar Bari, Anurag and Abdellati, Saïd and Vanbaelen, Thibaut and De Baetselier, Irith and de Block, Tessa and Naesens, Reinout and Britto Xavier, Basil and Rossen, John and Kenyon, Chris and Manoharan-Basil, Sheeba Santhini},
  title = {Characterizing ceftriaxone tolerance in Neisseria gonorrhoeae across in vitro and in vivo models},
  journal = {mSystems},
  year = {2026},
  doi = {10.1128/msystems.01298-25}
}
Kostenlos starten →